Contrary to popular belief, initial public offerings are still occurring in the med-tech space. The most recent IPO comes from Globus Medical (Audubon, Pennsylvania), a spinal implant manufacturer. The company said that it is expecting its IPO of 11.76 million shares to be priced somewhere between $16 and $18 a piece.

Despite the belief that big exits in the device space are rare, a report from Silicon Valley Bank (SVB; Santa Clara, California) shows otherwise, offering up data that suggests there was good exit activity across multiple indications.

The Patient-Centered Outcomes Research Institute (PCORI; Washington), a government effort to drive medical research into comparative effectiveness, reported the start of a public comment period for its draft methodology report, which proposes standards for the conduct of patient-centered outcomes research (PCOR).